Laser light combined with a photosensitizer may eliminate methicillin-resistant strains of Staphylococcus aureus

Area of Science:

• Photodynamic Therapy
• Antimicrobial Research
• Medical Laser Applications

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) is a significant global cause of hospital-acquired infections, particularly in wound, burn, and systemic infections.
• Effective treatment strategies against MRSA are crucial due to rising antimicrobial resistance.
• Photodynamic therapy (PDT) presents a potential alternative or adjunct to conventional antimicrobial treatments.

Purpose of the Study:

• To evaluate the efficacy of a helium-neon (HeNe) laser combined with toluidine blue O (TBO) dye in reducing the viability of MRSA isolates.
• To determine the optimal exposure time for achieving significant MRSA killing using this combination therapy.

Main Methods:

• MRSA isolates were obtained from clinical samples and carrier screening.
• Isolates were exposed to a 632.8 nm HeNe laser (7.5 mW) with 50 µg/ml TBO photosensitizer for 5, 10, and 15 minutes.
• Control groups included MRSA exposed to the laser alone.
• The plate count method was used to determine the viable bacterial count post-exposure.

Main Results:

• Exposure to the HeNe laser alone showed no significant effect on MRSA viability.
• The combination of HeNe laser and TBO resulted in a substantial decrease in MRSA viable counts.
• A 15-minute exposure to the HeNe laser with TBO achieved 100% eradication of MRSA under in vitro conditions.

Conclusions:

• The combination of a 632.8-nm HeNe laser and TBO is a highly effective method for eradicating MRSA in vitro.
• This photodynamic approach offers a promising non-antibiotic strategy for combating MRSA infections.
• Further research into clinical applications of this PDT method for MRSA is warranted.